Diferencia entre revisiones de «Template:Typhoid Antibiotics»
Sin resumen de edición |
(Convert to AntibioticDose with disease=Typhoid fever) |
||
| Línea 1: | Línea 1: | ||
====Oral therapy with [[Quinolone]] Susceptibility==== | ====Oral therapy with [[Quinolone]] Susceptibility==== | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Ciprofloxacin|dose=500-750 mg PO q 12 hrs x 14 days|context=Quinolone Susceptible, Oral}} | ||
====Parenteral Therapy with [[Quinolone]] Susceptibility==== | ====Parenteral Therapy with [[Quinolone]] Susceptibility==== | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Ciprofloxacin|dose=400 mg IV q 12 hrs x 10 days|context=Quinolone Susceptible, Parenteral}} | ||
====Parenteral Therapy with [[Quinolone]] Resistance==== | ====Parenteral Therapy with [[Quinolone]] Resistance==== | ||
:''if nalidixic acid resistant, assume [[fluoroquinolone]] resistant'' | :''if nalidixic acid resistant, assume [[fluoroquinolone]] resistant'' | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Ceftriaxone|dose=2g IV q 24 hrs x 14 days|context=Quinolone Resistant, Parenteral}} | ||
::'''OR''' | ::'''OR''' | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Cefixime|dose=10-15 mg/kg IV q 12 hrs x 8 days|context=Quinolone Resistant, Parenteral}} | ||
====Oral Therapy with [[Quinolone]] Resistance==== | ====Oral Therapy with [[Quinolone]] Resistance==== | ||
* | *{{AntibioticDose|disease=Typhoid fever|drug=Azithromycin|dose=1 g PO daily x 5 days|context=Quinolone Resistant, Oral}} | ||
Revisión del 23:32 19 mar 2026
Oral therapy with Quinolone Susceptibility
- Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days
Parenteral Therapy with Quinolone Susceptibility
- Ciprofloxacin 400 mg IV q 12 hrs x 10 days
Parenteral Therapy with Quinolone Resistance
- if nalidixic acid resistant, assume fluoroquinolone resistant
- Ceftriaxone 2g IV q 24 hrs x 14 days
- OR
- Cefixime 10-15 mg/kg IV q 12 hrs x 8 days
Oral Therapy with Quinolone Resistance
- Azithromycin 1 g PO daily x 5 days